The main drivers of diagnostic errors in 2023 were issues with processing medical tests, referrals and communication, according to the Emergency Care Research Institute. Nearly 7 in 10 errors occur ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...

ORANGE COUNTY, Calif.--(BUSINESS WIRE)--PHASE Scientific Americas (PHASE Scientific), a fast-growing, global biomedical company developing innovative solutions to revolutionize healthcare diagnostics, ...

Avalon Healthcare Solutions ("Avalon"), a trusted partner for Diagnostic Intelligence across the payer ecosystem, today ...

In a significant effort to speed up diagnosis of serious infections - a move that experts say could also help reduce ...

With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex era.

A Hong Kong-based developer of a catalog of urine-based tests for cancer, infectious diseases, women’s health and more has raised $34 million in venture capital funds to increase its global commercial ...

Hong Kong-headquartered biotech company PHASE Scientific International has completed a Series A funding round, raising $34m for progressing PHASIFY, a urine-based diagnostic technology for early ...

Personalised healthcare is both the future and the present, says James Goolnik – and diagnostics, he argues, are the key to ...